发明申请
US20110038858A1 METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
审中-公开
使用PNP抑制剂治疗血浆癌的方法，如用烷基化剂与抗病毒剂或抗CD20药剂联合使用
- 专利标题： METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
- 专利标题（中）： 使用PNP抑制剂治疗血浆癌的方法，如用烷基化剂与抗病毒剂或抗CD20药剂联合使用
-
申请号： US12747456申请日： 2008-12-10
-
公开(公告)号： US20110038858A1公开(公告)日： 2011-02-17
- 发明人: Shanta Bantia , Philip Breitfeld , Yarlagadda S. Babu
- 申请人： Shanta Bantia , Philip Breitfeld , Yarlagadda S. Babu
- 申请人地址： US AL Birmingham
- 专利权人： Biocryst Pharmaceuticals, Inc.
- 当前专利权人： Biocryst Pharmaceuticals, Inc.
- 当前专利权人地址： US AL Birmingham
- 国际申请： PCT/US08/86256 WO 20081210
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; A61K39/395 ; A61K31/4184 ; A61P35/00
摘要：
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
信息查询
IPC分类:
